Anti-Chlamydia tr.-IgG (IgG class antibodies to Chlamydia trachomatis)

Brief description of the study "IgG antibodies to Chlamydia trachomatis" Chlamydia are obligate intracellular gram-negative parasites, among which Chlamydia trachomatis and Chlamydia pneumoniae are the most significant as causative agents of human diseases. Chlamydia trachomatis is the causative agent of a widespread infection that is transmitted mainly sexually and causes chlamydia - a lesion of the mucous membranes of the genital tract and conjunctiva. Chlamydia can be asymptomatic, often chronic, accompanied by various complications that in women can cause infertility and miscarriage. Chlamydia trachomatis is often resistant to therapy. Reactivation of the infection can occur due to changes in the immune or hormonal status, trauma, surgery, stress. Chlamydia trachomatis has low immunogenicity, as a result of which antibodies are not detected in 50% of infected people. Therefore, the microorganism is detected by a highly sensitive and specific direct method - PCR. IgG antibodies to Chlamydia trachomatis antigens appear 15-20 days after infection. They persist for several years, sometimes even for life ("serological scar"). The presence of anti-Chlamydia IgG indicates a previous chlamydial infection. These are specific highly active antibodies, but they do not provide persistent immunity to infection. The level of IgG antibodies decreases with recovery and attenuation of the process, and increases with acute infection. For what purpose are IgG antibodies to Chlamydia trachomatis determined The study is carried out to establish the fact of infection with chlamydia, as well as to determine the stage of the disease with symptoms of chlamydia.

Rules for preparation for the study "IgG antibodies to Chlamydia trachomatis" No special preparation is required. It is recommended to take blood no earlier than 4 hours after the last meal.